Prof Workman talks to ecancertv at TAT 2015 about his work on the cancer genome and how this knowledge can be harnessed to help improve drug discovery and hopefully overcome resistance to molecularly targeted therapies.

He also discusses his research on developing inhibitors to the heat shock protein (HSP) 90 molecular chaperone and the PI3 kinase family of signalling enzymes.